GWPH - GW Pharmaceuticals plc

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 53.62B
Enterprise Value 33.02B
Trailing P/E N/A
Forward P/E 1-39.82
PEG Ratio (5 yr expected) 10.34
Price/Sales (ttm)329.54
Price/Book (mrq)8.92
Enterprise Value/Revenue 3274.81
Enterprise Value/EBITDA 6-15.84

Financial Highlights

Fiscal Year

Fiscal Year Ends Sep 30, 2017
Most Recent Quarter (mrq)Sep 30, 2017


Profit Margin 0.00%
Operating Margin (ttm)-1,799.36%

Management Effectiveness

Return on Assets (ttm)-23.57%
Return on Equity (ttm)-38.92%

Income Statement

Revenue (ttm)10.97M
Revenue Per Share (ttm)0.43
Quarterly Revenue Growth (yoy)28.30%
Gross Profit (ttm)6.3M
EBITDA -190.37M
Net Income Avi to Common (ttm)-175.38M
Diluted EPS (ttm)-6.94
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)321.2M
Total Cash Per Share (mrq)12.66
Total Debt (mrq)17.72M
Total Debt/Equity (mrq)4.78
Current Ratio (mrq)7.59
Book Value Per Share (mrq)14.60

Cash Flow Statement

Operating Cash Flow (ttm)-146.83M
Levered Free Cash Flow (ttm)-127.65M

Trading Information

Stock Price History

Beta 2.39
52-Week Change 315.40%
S&P500 52-Week Change 317.21%
52 Week High 3136.95
52 Week Low 392.65
50-Day Moving Average 3118.15
200-Day Moving Average 3108.64

Share Statistics

Avg Vol (3 month) 3405.99k
Avg Vol (10 day) 3537.43k
Shares Outstanding 527.77M
Float 21.28M
% Held by Insiders 10.00%
% Held by Institutions 183.65%
Shares Short 33.24M
Short Ratio 311.61
Short % of Float 30.00%
Shares Short (prior month) 33.45M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A